What is your preferred regimen for HDR monotherapy in the treatment of low and favorable intermediate prostate cancers?  

At UCLA, we now use 13.5 Gy x 2 fractions for most cases. The two implants are done 4-7 days apart (some cases are Monday and Friday). We also use this program for some favorable high-risk-group patients.@Albert J. Chang (brachytherapy division director) uses slightly different dose constraints...

We also use the 2 x 1350 regimen that Drs Martinez and Ghilizan helped pioneer at Beaumont. We have done it for over 11 years at our center with over 600 patients. We are assessing BCFS at present and with a median follow up of 62 months, there are excellent results with relatively low long-term gr...